Northwoods NETS

Wren Labs to Visit Northwoods NETS
news

Nancy Teixeira, who is a Carcinoid cancer patient, registered nurse and the Administrator/Nurse Clinician for Wren Laboratories, LLC will be presenting to Northwoods NETS on May 18th at Fairview Ridges Hospital in Burnsville, MN. She will begin her talk at 2pm, one hour before our normal support group meeting. Nancy has been living with the diease for over 18 years. Wren has developed an exciting state-of-the-art molecular biomarker test called the NETest that trends

Dr. Vargas Presents to Northwoods NETS - Video & Powerpoint
news

Northwoods NETS was extremely lucky to have Dr. Luciano Vargas from the University of Nebraska Medical Center present to us on March 9, 2014. He is part of a multi-disciplinary team that works specifically with patients living with neuroendocrine cancers. At 51:00 My first first camera’s battery died, so it was switched out to a mobile, handheld device. The video and audio quality changes, but it is still okay. Special

Dr. Vargas presents to Northwoods NETS
website

On Sunday, March 9th, 2014, the Neuroendocrine Tumor Program team of Nebraska Medical Center presented their multidisciplinary approach to Northwoods NETS. Dr. Luciano Vargas gave a very informative speech that was a good primer about neuroendocrine tumors in general, as well as how their center approaches this disease. [embedplusvideo height=”450″ width=”584″ editlink=”http://bit.ly/1kkv8no” standard=”http://www.youtube.com/v/Orlery1YSV4?fs=1″ vars=”ytid=Orlery1YSV4&width=584&height=450&start=&stop=&rs=w&hd=0&autoplay=0&react=1&chapters=&notes=” id=”ep4986″ /]

2014 NET Patient Conference has been announced
news

A conference that includes all types of neuroendocrine tumor patients including mid-gut ‘noids, Lungnoids, P-Net patients and more. get ready for another fantastic lineup featuring over 20 world class NET experts presenting the information you need to make informed decisions about your health. Some of the topics are brand-new and just published, sprinkled in with advice from the experts on the top issues faced by NET patients. Topics that will be covered welcome an audience of all levels,

Unprecedented Responses Seen in Neuroendocrine Tumors
news

Summary: Robert Fine, MD, reported at a press conference held in advance of the 2014 Gastrointestinal Cancers Symposium (GICS), that the chemotherapy combination of capecitabine plus temozolomide either stalled disease progression or shrank tumors in 97% of patients whose disease had worsened after standard high-dose octreotide. Read the full story at Medscape. You can sign up for a free account to access the full article.